Max Ruzanov currently serves as a Principal Scientist at Bristol-Myers Squibb, where he leverages his extensive expertise in molecular biology and biochemistry to drive innovative drug discovery initiatives. With a strong focus on protein expression, purification, and characterization, Max plays a pivotal role in elucidating...
Max Ruzanov currently serves as a Principal Scientist at Bristol-Myers Squibb, where he leverages his extensive expertise in molecular biology and biochemistry to drive innovative drug discovery initiatives. With a strong focus on protein expression, purification, and characterization, Max plays a pivotal role in elucidating the structural and functional properties of drug targets. His proficiency in advanced techniques such as X-ray crystallography and Cryo-Electron Microscopy (Cryo-EM) enables him to provide critical insights into the molecular mechanisms underlying various diseases, facilitating the development of novel therapeutics.
Max's work is characterized by his commitment to biophysical characterization, where he employs a range of analytical methods to assess the interactions between drug candidates and their targets. This meticulous approach not only enhances the understanding of drug efficacy but also informs the optimization of lead compounds, ultimately accelerating the drug development pipeline. His contributions to key projects at Bristol-Myers Squibb have been instrumental in advancing several promising candidates through preclinical stages, showcasing his ability to translate complex scientific concepts into actionable strategies.
Beyond his technical skills, Max is also passionate about nonprofit volunteering, where he applies his scientific knowledge to benefit the community. His dedication to science outreach and education reflects a holistic approach to his career, emphasizing the importance of collaboration and knowledge sharing in the scientific community. As a leader in his field, Max Ruzanov continues to make significant strides in drug discovery, embodying the innovative spirit that drives Bristol-Myers Squibb’s mission to deliver transformative medicines to patients in need.
